Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Celldex Therapeutics, Inc](/topic/$cldx)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cldx/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$cldx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**6 Months**: XXX% +80%  
**1 Year**: XXX% no change  
**1-Year High**: XXX% on 2024-07-19  
**1-Year Low**: X% on 2024-08-02  

**Most Supportive Themes**
- **Positive Sentiment:** (49%) High positive sentiment is present surrounding Celldex Therapeutics (CLDX), particularly regarding its potential in urticaria and positive assessments.
- **Potential in Urticaria:** (49%) There is significant discussion about Celldex Therapeutics (CLDX) and its potential in the chronic urticaria market.
  
**Most Critical Themes**
- **Market Concerns:** (2%)  Concerns about market performance and valuation are present in the discussion.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Celldex Therapeutics, Inc

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +80%
1 Year: XXX% no change
1-Year High: XXX% on 2024-07-19
1-Year Low: X% on 2024-08-02

Most Supportive Themes

  • Positive Sentiment: (49%) High positive sentiment is present surrounding Celldex Therapeutics (CLDX), particularly regarding its potential in urticaria and positive assessments.
  • Potential in Urticaria: (49%) There is significant discussion about Celldex Therapeutics (CLDX) and its potential in the chronic urticaria market.

Most Critical Themes

  • Market Concerns: (2%) Concerns about market performance and valuation are present in the discussion.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% X X%
Total XXX XX% XXX XX% X X%
Celldex Therapeutics, Inc (CLDX) Sentiment
/topic/$cldx/sentiment